{"id":"W2234278652","doi":"10.1185/03007995.2016.1140030","title":"Treatment patterns, overall survival, healthcare resource use and costs in elderly Medicare beneficiaries with chronic myeloid leukemia using second-generation tyrosine kinase inhibitors as second-line therapy","year":2016,"lang":"en","type":"article","venue":"Current Medical Research and Opinion","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Nilotinib; Medicine; Dasatinib; Hazard ratio; Internal medicine; Myeloid leukemia; Imatinib; Medicare Advantage; Medicare Part D; Emergency medicine; Health care; Medical prescription; Confidence interval; Pharmacology; Prescription drug","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004506252,0.0001541545,0.0002920008,0.0007101084,0.0003173375,0.0004533266,0.0002211655,0.0003595117,0.0009905127],"category_scores_gemma":[0.001664429,0.0001230455,0.0004413358,0.001033811,0.0001354738,0.0004557378,0.0003674421,0.0003112381,0.0001291082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004337262,"about_ca_system_score_gemma":0.0002971857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009556763,"about_ca_topic_score_gemma":0.01483972,"domain_scores_codex":[0.9996248,0.00008413237,0.00007237505,0.00007634638,0.00006301452,0.00007933213],"domain_scores_gemma":[0.9989354,0.0001299002,0.0007101555,0.00002599489,0.00006700715,0.0001314504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004224725,0.00002501411,0.9991238,0.000003936103,0.00002900359,0.00001490634,0.0000255357,0.00002022513,0.00002763615,0.000004738374,0.00005407707,0.00062903],"study_design_scores_gemma":[0.000004839494,0.00005012986,0.9994276,0.000005768132,0.00001411485,0.00009006593,0.0001637621,0.0001469678,0.00001706144,0.00001070333,0.00006731707,0.000001770386],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993483,0.0001790102,0.00001403381,0.00003993919,0.000001477093,0.000003120597,0.0003187367,6.596569e-7,0.00009467767],"genre_scores_gemma":[0.9993538,0.0001168325,0.00003114688,0.00003697026,0.000005502985,0.000006384744,0.0003855599,4.553075e-7,0.00006331896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009556763,"threshold_uncertainty_score":0.01900226,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.113889797740799,"score_gpt":0.3880523490510253,"score_spread":0.2741625513102264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}